The interaction of alpha-mangostin and its derivatives against main protease enzyme in COVID-19 using in silico methods

The interaction of alpha-mangostin and its derivatives against main protease enzyme in COVID-19 using in silico methods

More than 111 million people worldwide have been affected by the COVID-19 outbreak caused by SARS-CoV-2. The main therapeutic target of COVID-19 is main protease (Mpro). It plays a key role as an enzyme in the SARS-CoV-2 replication and transcription. In this case, the alpha-mangostin potentially ha...

Full description

Bibliographic Details
Main Authors: Syahrul Hidayat, Faisal Maulana Ibrahim, Kelvin Fernando Pratama, Muchtaridi Muchtaridi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Journal of Advanced Pharmaceutical Technology & Research
Subjects:
alpha-mangostin
covid-19
in silico
main protease
Online Access:http://www.japtr.org/article.asp?issn=2231-4040;year=2021;volume=12;issue=3;spage=285;epage=290;aulast=Hidayat

Internet

http://www.japtr.org/article.asp?issn=2231-4040;year=2021;volume=12;issue=3;spage=285;epage=290;aulast=Hidayat

Similar Items